Krister, review the Nir Barzilai interview in detail.
@anon16510610 yes, that is one interesting trial. Lets create a thread on community driven rapamycin trials.
@Joseph I listened to that podcast some years ago when I deep dived in the metformin area. What in that episode did you want to highlight?
This is rather interesting… navitor has out-licenced a compound that I think is an motor inhibitor, for use in depression…
https://www.fiercebiotech.com/biotech/supernus-links-depression-drug-fast-responses-small-trial
Yes, I saw David Sabatini reposted about that on X. Very interesting but it seem like its a mTORC1 activator?
Supernus Pharmaceuticals has linked its mTORC1 activator to rapid improvements in adults with major depressive disorder (MDD) in a small trial
Here is one presentation that I also found about the trial
https://ir.supernus.com/static-files/ab65cf23-b874-4b16-819b-13eb197962e7
And one video where they talk a little bit about the trial
Good info - thanks. I assumed it was an mTOR inhibitor as that was, I believe, the focus on Navitor, but perhaps they are more broadly looking at all types of mTOR related molecules.